| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.04 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.09 | 0.04 |